Papers

1

Total Citations

4

H-Index

1

About

Julie Chu is a leading radiation oncologist whose work focuses on advancing stereotactic radiosurgery (SRS) and optimizing treatment for patients with brain metastases. Her research centers on the safety and efficacy of single-isocenter multitarget SRS, a technique that allows for the simultaneous treatment of multiple brain lesions with high precision. In her most-cited paper, "Single-Isocenter Multitarget Stereotactic Radiosurgery is Safe and Effective in the Treatment of Multiple Brain Metastases" (2019), Chu and her colleagues demonstrated that this approach offers excellent local control while minimizing radiation exposure to healthy brain tissue, reducing treatment times and improving patient comfort. With 4 citations, this work has contributed to the growing adoption of streamlined SRS protocols in clinical practice. Chu's contributions are particularly notable for bridging technical innovation with patient-centered outcomes, making her a respected voice in neuro-oncology and radiosurgery. Her research continues to shape how clinicians approach complex metastatic disease, emphasizing both efficacy and quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Single-Isocenter Multitarget Stereotactic Radiosurgery is Safe and Effective in the Treatment of Multiple Brain Metastases
4 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: The Ohio State University Wexner Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago